The global corneal topographers market size is expected to reach USD 915.6 million by the end of 2027, expanding at a CAGR of 4.8%, according to a new report by Grand View Research, Inc. Increasing incidence of ophthalmic disorders including cataract and diabetic retinopathy is expected to accelerate market growth. According to the Centers of Disease Control and Prevention (CDC), 2015, 20.5 million Americans were cataract patients, out of which, 6.1 million people underwent cataract surgery. CDC further stated that the patient population suffering from cataracts is estimated to escalate to 30.1 million by 2020.
Growing efforts of government organizations to increase awareness and reach an effective ophthalmic care through ambulatory centers are expected to bolster market growth. For instance, the International Agency for the Prevention of Blindness (IAPB) and the World Health Organization (WHO) launched an initiative named Right to Sight, intending to eliminate preventable vision loss in patients suffering from various eye conditions.
Frequent new product approval is expected to aid corneal topographers market growth during the forecast period. For instance, in January 2017, the U.S. FDA approved Aladdin corneal topographer HW3.0 developed by Topcon Medical Systems for distribution in U.S. The new version includes features such as central pachymetry, toric IOL calculator, thereby allowing precision diagnosis.
Browse Full Report (Tables & Figures) @ https://www.grandviewresearch.com/industry-analysis/corneal-topographers-market
Contact Us:
Grand View Research, Inc.
201 Spear Street 1100,
San Francisco, CA 94105
United States
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: [email protected]